VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+3.91%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$245M
AUM Growth
+$31M
(+15%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
12.58%
Top 10 Holdings %
Top 10 Hldgs %
7.31%
Holding
511
New
57
Increased
251
Reduced
151
Closed
49
Top Buys
| 1 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$1.88M |
| 2 |
DocuSign
DOCU
|
$1.49M |
| 3 |
United Airlines
UAL
|
$1.47M |
| 4 |
Fortinet
FTNT
|
$1.35M |
| 5 |
Spotify
SPOT
|
$1.34M |
Top Sells
| 1 |
Applovin
APP
|
$1.45M |
| 2 |
Expedia Group
EXPE
|
$1.04M |
| 3 |
KKR & Co
KKR
|
$976K |
| 4 |
CME Group
CME
|
$974K |
| 5 |
Corpay
CPAY
|
$948K |
Sector Composition
| 1 | Financials | 29.48% |
| 2 | Technology | 14.86% |
| 3 | Healthcare | 14.81% |
| 4 | Industrials | 11.61% |
| 5 | Consumer Discretionary | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFT
176
Eaton Vance Floating-Rate Income Trust
EFT
$319M
| $707K | 0.29% |
55,087
+5,064
| +10% | +$65K |
|
177
BlackRock Floating Rate Income Strategies Fund
FRA
$471M
| $698K | 0.28% |
50,742
+1,331
| +3% | +$18.3K |
|
|
BSL
178
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
| $665K | 0.27% |
46,387
+6,271
| +16% | +$89.9K |
|
179
Gladstone Capital
GLAD
$582M
| $591K | 0.24% |
20,796
-4,785
| -19% | -$136K |
|
180
Main Street Capital
MAIN
$5.95B
| $581K | 0.24% |
9,910
+386
| +4% | +$22.6K |
|
|
MPV
181
Barings Participation Investors
MPV
$209M
| $579K | 0.24% |
33,899
+8,122
| +32% | +$139K |
|
182
OFS Capital
OFS
$117M
| $519K | 0.21% |
64,344
+8,784
| +16% | +$70.9K |
|
183
Monroe Capital Corp
MRCC
$164M
| $517K | 0.21% |
60,862
+3,810
| +7% | +$32.4K |
|
|
BCIC
184
BCP Investment Corporation Common Stock
BCIC
$160M
| $488K | 0.2% |
29,852
+6,031
| +25% | +$98.5K |
|
185
WhiteHorse Finance
WHF
$204M
| $476K | 0.19% |
49,129
-27,747
| -36% | -$269K |
|
186
Oxford Square Capital
OXSQ
$172M
| $464K | 0.19% |
190,194
+39,466
| +26% | +$96.3K |
|
187
Ironwood Pharmaceuticals
IRWD
$188M
| $435K | 0.18% |
98,218
+43,143
| +78% | +$191K |
|
188
Tarsus Pharmaceuticals
TARS
$2.43B
| $379K | 0.15% |
6,845
-3,093
| -31% | -$171K |
|
189
Harmony Biosciences
HRMY
$2.07B
| $378K | 0.15% |
10,975
-92
| -0.8% | -$3.17K |
|
190
Neurocrine Biosciences
NBIX
$14.3B
| $376K | 0.15% |
2,758
+341
| +14% | +$46.5K |
|
191
Acadia Pharmaceuticals
ACAD
$4.26B
| $372K | 0.15% |
20,258
-1,568
| -7% | -$28.8K |
|
192
Ascendis Pharma
ASND
$12.5B
| $368K | 0.15% |
2,676
+100
| +4% | +$13.8K |
|
|
ONC
193
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $358K | 0.15% |
1,940
-39
| -2% | -$7.2K |
|
194
Madrigal Pharmaceuticals
MDGL
$9.65B
| $357K | 0.15% |
1,156
-33
| -3% | -$10.2K |
|
195
Phathom Pharmaceuticals
PHAT
$875M
| $356K | 0.15% |
43,789
+13,711
| +46% | +$111K |
|
196
Gilead Sciences
GILD
$143B
| $353K | 0.14% |
3,817
-1,365
| -26% | -$126K |
|
197
Rhythm Pharmaceuticals
RYTM
$6.78B
| $352K | 0.14% |
6,280
-1,143
| -15% | -$64K |
|
|
ITCI
198
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $350K | 0.14% |
4,193
-621
| -13% | -$51.9K |
|
199
Halozyme
HALO
$8.76B
| $349K | 0.14% |
7,310
+673
| +10% | +$32.2K |
|
200
Roivant Sciences
ROIV
$8.82B
| $348K | 0.14% |
29,432
-1,035
| -3% | -$12.2K |
|